Illness Remission: Anathema to Compliance with Hypertensive Therapy

Joel Olayiwola Faronbi; Ayodele Feyi Ojo; Alinane Linda Nyondo Mipando

doi:doi:10.11648/j.cajph.20180403.13

| Peer-Reviewed

Illness Remission: Anathema to Compliance with Hypertensive Therapy

Joel Olayiwola Faronbi, Ayodele Feyi Ojo, Alinane Linda Nyondo Mipando

Published in Central African Journal of Public Health (Volume 4, Issue 3)

Received: 2 June 2018 Accepted: 28 June 2018 Published: 4 August 2018

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background: Hypertension is a chronic and persisting illness that can be difficult to treat. The success of management of hypertension depends on adherence to the treatment regimen. The objective of this study was to explore barriers and facilitators to compliance with hypertensive drug treatment among patients in Nigeria. Method: Twenty hypertensive patients were purposively selected and participated in in-depth interviews where their experiences with hypertensive treatments were explored. Interview sessions were audio recorded and transcribed verbatim and imported into Nvivo. Data was analysed using content analysis. Results: Four interrelated themes explain barriers to full compliance among to treatment among hypertensive patients as follows: (i) Temporary remission of symptoms, (ii) Dissatisfaction with Service, (iii) Navigating the Health Care Services, and (iv) Desire for Improved Functionality. Conclusion: This study concluded that lack of understanding of the chronical nature of hypertension hinders the participants from complying with treatment. It also identified inaccessible and poor quality services as a barrier to seeking treatment while the desire to regain functionality serves as a significant impetus for continuing with the treatment. Therefore, health professionals should endeavour to provide adequate health education on compliance with treatment while government should provide quality and affordable hypertensive care to citizens.

Published in	Central African Journal of Public Health (Volume 4, Issue 3)
DOI	10.11648/j.cajph.20180403.13
Page(s)	69-75
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Barrier, Compliance, Hypertensive, In-Depth Interview, Motivator and Remission

References

[1]	Gupta, R. and D. Xavier, Hypertension: The Most Important Non Communicable Disease Risk Factor in India. Indian Heart Journal, 2018.
[2]	Akinroye, K., Nigerians wake up to high blood pressure. Bull World Health Organ, 2013. 91: p. 242-243.
[3]	Anchala, R., et al., Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. Journal of hypertension, 2014. 32(6): p. 1170.
[4]	Akinlua, J. T., et al., Current prevalence pattern of hypertension in Nigeria: A systematic review. PloS one, 2015. 10(10): p. e0140021.
[5]	Ajayi, I., et al., Blood pressure pattern and hypertension related risk factors in an urban community in Southwest Nigeria: The Mokola hypertension initiative project, Ibadan, Nigeria. Journal of Public Health and Epidemiology, 2017. 9(4): p. 51-64.
[6]	Steel, Z., et al., The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013. International journal of epidemiology, 2014: p. dyu038.
[7]	Ogundipe, S. and C. Obinna, Hypertension: Why FG must act now, in Vanguard Newspaper, April 9 2013. 2013, Vanguard Newspaper: Lagos.
[8]	Kones, R., Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug design, development and therapy, 2011. 5: p. 325.
[9]	Martin, L. R., et al., The challenge of patient adherence. Ther Clin Risk Manag, 2005. 1(3): p. 189-199.
[10]	Vrijens, B., et al., Current situation of medication adherence in hypertension. Frontiers in pharmacology, 2017. 8: p. 100.
[11]	van Boven, J. F., et al., Clinical and economic impact of non-adherence in COPD: a systematic review. Respiratory medicine, 2014. 108(1): p. 103-113.
[12]	Jin, J., et al., Factors affecting therapeutic compliance: A review from the patient's perspective. Therapeutics and clinical risk management, 2008. 4(1): p. 269.
[13]	Martin, L. R., et al., The challenge of patient adherence. Therapeutics and clinical risk management, 2005. 1(3): p. 189.
[14]	Amira, C. and N. Okubadejo, Factors influencing non-compliance with anti-hypertensive drug therapy in Nigerians. The Nigerian postgraduate medical journal, 2007. 14(4): p. 325-329.
[15]	Kabir, M., et al., Compliance to medication among hypertensive patients in Murtala Mohammed Specialist Hospital, Kano, Nigeria. Journal of Community medicine and primary health care, 2004. 16(1): p. 16-20.
[16]	Osamor, P. E. and B. E. Owumi, Factors associated with treatment compliance in hypertension in southwest Nigeria. J Health Popul Nutr, 2011. 29(6): p. 619-28.
[17]	Becker, M. H., The health belief model and sick role behavior. Health Education & Behavior, 1974. 2(4): p. 409-419.
[18]	Hsieh, H.-F. and S. E. Shannon, Three approaches to qualitative content analysis. Qualitative health research, 2005. 15(9): p. 1277-1288.
[19]	Strauss, A. and J. Corbin, Basics of qualitative research: Procedures and techniques for developing grounded theory. 1998, Thousand Oaks, CA: Sage.
[20]	Sahay, S., K. S. Reddy, and S. Dhayarkar, Optimizing adherence to antiretroviral therapy. Indian Journal of Medical Research, 2011. 134(6): p. 835.
[21]	World Health Organization Stop TB Initiative, Treatment of tuberculosis: guidelines. 2010: World Health Organization.
[22]	Vermeire, E., et al., Patient adherence to treatment: three decades of research. A comprehensive review. Journal of clinical pharmacy and therapeutics, 2001. 26(5): p. 331-342.
[23]	De Pascual-Verdú, R., M. Rocha-Díaz, and G. Almazán-Antón, Relevant factors in treatment adherence: A case study. Clínica y Salud, 2015. 26(3): p. 141-150.
[24]	Brown, M. T. and J. K. Bussell. Medication adherence: WHO cares? In Mayo Clinic Proceedings. 2011. Elsevier.
[25]	Haddad, P. M., C. Brain, and J. Scott, Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat Outcome Meas, 2014. 5: p. 43-62.
[26]	DiMatteo, M. R., K. B. Haskard, and S. L. Williams, Health beliefs, disease severity, and patient adherence: a meta-analysis. Medical care, 2007. 45(6): p. 521-528.
[27]	Akoko, B. M., et al., Knowledge of hypertension and compliance with therapy among hypertensive patients in the Bamenda Health District of Cameroon: a cross-sectional study. Cardiology and therapy, 2017. 6(1): p. 53-67.
[28]	Jurkiewicz, M. T., S. Marzolini, and P. Oh, Adherence to a home-based exercise program for individuals after stroke. Topics in stroke rehabilitation, 2015.
[29]	Sabaté, E., Adherence to long-term therapies: evidence for action. 2003: World Health Organization.
[30]	Bokhour, B. G., et al., The role of patients’ explanatory models and daily-lived experience in hypertension self-management. Journal of general internal medicine, 2012. 27(12): p. 1626-1634.
[31]	Mosadeghrad, A. M., Factors influencing healthcare service quality. International journal of health policy and management, 2014. 3(2): p. 77.
[32]	Zimmerman, E. B., S. H. Woolf, and A. Haley, Understanding the relationship between education and health: a review of the evidence and an examination of community perspectives. Population health: behavioral and social science insights. Rockville (MD): Agency for Health-care Research and Quality, 2015: p. 347-84.
[33]	Gulliford, M., et al., What does' access to health care'mean? Journal of health services research & policy, 2002. 7(3): p. 186-188.
[34]	Sienkiewicz, D., Access to Health Services in Europe. European Social Watch Report, 2010. 2010: p. 17-20.
[35]	Siegel, D., Barriers to and strategies for effective blood pressure control. Vasc Health Risk Manag, 2005. 1(1): p. 9-14.
[36]	Taddeo, D., M. Egedy, and J.-Y. Frappier, Adherence to treatment in adolescents. Paediatr Child Health, 2008. 13(1): p. 19-24.
[37]	Malik, A., et al., Hypertension-related knowledge, practice and drug adherence among inpatients of a hospital in Samarkand, Uzbekistan. Nagoya journal of medical science, 2014. 76(3-4): p. 255.
[38]	Gray, A., Access to medicines and drug regulation in developing countries: a resource guide for DFID. London: DFID Health Systems Resource Centre, 2004.

Cite This Article

Plain Text BibTeX RIS

APA Style

Joel Olayiwola Faronbi, Ayodele Feyi Ojo, Alinane Linda Nyondo Mipando. (2018). Illness Remission: Anathema to Compliance with Hypertensive Therapy. Central African Journal of Public Health, 4(3), 69-75. https://doi.org/10.11648/j.cajph.20180403.13

Copy | Download

ACS Style

Joel Olayiwola Faronbi; Ayodele Feyi Ojo; Alinane Linda Nyondo Mipando. Illness Remission: Anathema to Compliance with Hypertensive Therapy. Cent. Afr. J. Public Health 2018, 4(3), 69-75. doi: 10.11648/j.cajph.20180403.13

Copy | Download

AMA Style

Joel Olayiwola Faronbi, Ayodele Feyi Ojo, Alinane Linda Nyondo Mipando. Illness Remission: Anathema to Compliance with Hypertensive Therapy. Cent Afr J Public Health. 2018;4(3):69-75. doi: 10.11648/j.cajph.20180403.13

Copy | Download

@article{10.11648/j.cajph.20180403.13,
  author = {Joel Olayiwola Faronbi and Ayodele Feyi Ojo and Alinane Linda Nyondo Mipando},
  title = {Illness Remission: Anathema to Compliance with Hypertensive Therapy},
  journal = {Central African Journal of Public Health},
  volume = {4},
  number = {3},
  pages = {69-75},
  doi = {10.11648/j.cajph.20180403.13},
  url = {https://doi.org/10.11648/j.cajph.20180403.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cajph.20180403.13},
  abstract = {Background: Hypertension is a chronic and persisting illness that can be difficult to treat. The success of management of hypertension depends on adherence to the treatment regimen. The objective of this study was to explore barriers and facilitators to compliance with hypertensive drug treatment among patients in Nigeria. Method: Twenty hypertensive patients were purposively selected and participated in in-depth interviews where their experiences with hypertensive treatments were explored. Interview sessions were audio recorded and transcribed verbatim and imported into Nvivo. Data was analysed using content analysis. Results: Four interrelated themes explain barriers to full compliance among to treatment among hypertensive patients as follows: (i) Temporary remission of symptoms, (ii) Dissatisfaction with Service, (iii) Navigating the Health Care Services, and (iv) Desire for Improved Functionality. Conclusion: This study concluded that lack of understanding of the chronical nature of hypertension hinders the participants from complying with treatment. It also identified inaccessible and poor quality services as a barrier to seeking treatment while the desire to regain functionality serves as a significant impetus for continuing with the treatment. Therefore, health professionals should endeavour to provide adequate health education on compliance with treatment while government should provide quality and affordable hypertensive care to citizens.},
 year = {2018}
}

Copy | Download

TY  - JOUR
T1  - Illness Remission: Anathema to Compliance with Hypertensive Therapy
AU  - Joel Olayiwola Faronbi
AU  - Ayodele Feyi Ojo
AU  - Alinane Linda Nyondo Mipando
Y1  - 2018/08/04
PY  - 2018
N1  - https://doi.org/10.11648/j.cajph.20180403.13
DO  - 10.11648/j.cajph.20180403.13
T2  - Central African Journal of Public Health
JF  - Central African Journal of Public Health
JO  - Central African Journal of Public Health
SP  - 69
EP  - 75
PB  - Science Publishing Group
SN  - 2575-5781
UR  - https://doi.org/10.11648/j.cajph.20180403.13
AB  - Background: Hypertension is a chronic and persisting illness that can be difficult to treat. The success of management of hypertension depends on adherence to the treatment regimen. The objective of this study was to explore barriers and facilitators to compliance with hypertensive drug treatment among patients in Nigeria. Method: Twenty hypertensive patients were purposively selected and participated in in-depth interviews where their experiences with hypertensive treatments were explored. Interview sessions were audio recorded and transcribed verbatim and imported into Nvivo. Data was analysed using content analysis. Results: Four interrelated themes explain barriers to full compliance among to treatment among hypertensive patients as follows: (i) Temporary remission of symptoms, (ii) Dissatisfaction with Service, (iii) Navigating the Health Care Services, and (iv) Desire for Improved Functionality. Conclusion: This study concluded that lack of understanding of the chronical nature of hypertension hinders the participants from complying with treatment. It also identified inaccessible and poor quality services as a barrier to seeking treatment while the desire to regain functionality serves as a significant impetus for continuing with the treatment. Therefore, health professionals should endeavour to provide adequate health education on compliance with treatment while government should provide quality and affordable hypertensive care to citizens.
VL  - 4
IS  - 3
ER  -

Copy | Download

Author Information

Joel Olayiwola Faronbi

Department of Nursing Science, College of Health Science, Obafemi Awolowo University, Ile-Ife, Nigeria
Ayodele Feyi Ojo

Department of Nursing Science, College of Health Science, Obafemi Awolowo University, Ile-Ife, Nigeria
Alinane Linda Nyondo Mipando

Department of Health Systems, School of Public Health and Family Medicine, College of Medicine, University of Malawi, Blantyre, Malawi

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Joel Olayiwola Faronbi, Ayodele Feyi Ojo, Alinane Linda Nyondo Mipando. (2018). Illness Remission: Anathema to Compliance with Hypertensive Therapy. Central African Journal of Public Health, 4(3), 69-75. https://doi.org/10.11648/j.cajph.20180403.13

Copy | Download

ACS Style

Joel Olayiwola Faronbi; Ayodele Feyi Ojo; Alinane Linda Nyondo Mipando. Illness Remission: Anathema to Compliance with Hypertensive Therapy. Cent. Afr. J. Public Health 2018, 4(3), 69-75. doi: 10.11648/j.cajph.20180403.13

Copy | Download

AMA Style

Joel Olayiwola Faronbi, Ayodele Feyi Ojo, Alinane Linda Nyondo Mipando. Illness Remission: Anathema to Compliance with Hypertensive Therapy. Cent Afr J Public Health. 2018;4(3):69-75. doi: 10.11648/j.cajph.20180403.13

Copy | Download

@article{10.11648/j.cajph.20180403.13,
  author = {Joel Olayiwola Faronbi and Ayodele Feyi Ojo and Alinane Linda Nyondo Mipando},
  title = {Illness Remission: Anathema to Compliance with Hypertensive Therapy},
  journal = {Central African Journal of Public Health},
  volume = {4},
  number = {3},
  pages = {69-75},
  doi = {10.11648/j.cajph.20180403.13},
  url = {https://doi.org/10.11648/j.cajph.20180403.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cajph.20180403.13},
  abstract = {Background: Hypertension is a chronic and persisting illness that can be difficult to treat. The success of management of hypertension depends on adherence to the treatment regimen. The objective of this study was to explore barriers and facilitators to compliance with hypertensive drug treatment among patients in Nigeria. Method: Twenty hypertensive patients were purposively selected and participated in in-depth interviews where their experiences with hypertensive treatments were explored. Interview sessions were audio recorded and transcribed verbatim and imported into Nvivo. Data was analysed using content analysis. Results: Four interrelated themes explain barriers to full compliance among to treatment among hypertensive patients as follows: (i) Temporary remission of symptoms, (ii) Dissatisfaction with Service, (iii) Navigating the Health Care Services, and (iv) Desire for Improved Functionality. Conclusion: This study concluded that lack of understanding of the chronical nature of hypertension hinders the participants from complying with treatment. It also identified inaccessible and poor quality services as a barrier to seeking treatment while the desire to regain functionality serves as a significant impetus for continuing with the treatment. Therefore, health professionals should endeavour to provide adequate health education on compliance with treatment while government should provide quality and affordable hypertensive care to citizens.},
 year = {2018}
}

Copy | Download

TY  - JOUR
T1  - Illness Remission: Anathema to Compliance with Hypertensive Therapy
AU  - Joel Olayiwola Faronbi
AU  - Ayodele Feyi Ojo
AU  - Alinane Linda Nyondo Mipando
Y1  - 2018/08/04
PY  - 2018
N1  - https://doi.org/10.11648/j.cajph.20180403.13
DO  - 10.11648/j.cajph.20180403.13
T2  - Central African Journal of Public Health
JF  - Central African Journal of Public Health
JO  - Central African Journal of Public Health
SP  - 69
EP  - 75
PB  - Science Publishing Group
SN  - 2575-5781
UR  - https://doi.org/10.11648/j.cajph.20180403.13
AB  - Background: Hypertension is a chronic and persisting illness that can be difficult to treat. The success of management of hypertension depends on adherence to the treatment regimen. The objective of this study was to explore barriers and facilitators to compliance with hypertensive drug treatment among patients in Nigeria. Method: Twenty hypertensive patients were purposively selected and participated in in-depth interviews where their experiences with hypertensive treatments were explored. Interview sessions were audio recorded and transcribed verbatim and imported into Nvivo. Data was analysed using content analysis. Results: Four interrelated themes explain barriers to full compliance among to treatment among hypertensive patients as follows: (i) Temporary remission of symptoms, (ii) Dissatisfaction with Service, (iii) Navigating the Health Care Services, and (iv) Desire for Improved Functionality. Conclusion: This study concluded that lack of understanding of the chronical nature of hypertension hinders the participants from complying with treatment. It also identified inaccessible and poor quality services as a barrier to seeking treatment while the desire to regain functionality serves as a significant impetus for continuing with the treatment. Therefore, health professionals should endeavour to provide adequate health education on compliance with treatment while government should provide quality and affordable hypertensive care to citizens.
VL  - 4
IS  - 3
ER  -

Copy | Download